Back to Search Start Over

Abstract C75: Diagnosing CRC in 3 vulnerable health centers in Santiago, Chile. Not an easy task

Authors :
Felipe Quezada
María Jesús Valdivieso
Javiera Martinez-Gutierrez
Viviana Rodríguez
Maria Elisa Herrera
Source :
Cancer Epidemiology, Biomarkers & Prevention. 27:C75-C75
Publication Year :
2018
Publisher :
American Association for Cancer Research (AACR), 2018.

Abstract

Colorectal cancer (CRC) is a common cancer worldwide. In Chile it is the third leading cause of cancer mortality. Its incidence rate is about 14 per 100,000 inhabitants. It is known that there is an inverse relationship between GDP per capita and CRC mortality. In Chile it is estimated that for every 3 people with CRC two deaths occur, while in the United States this number is one death per 6 people diagnosed. The Chilean Health care system is a dual one; the public sector serves >70% of the population with 50% of the resources. The private sector serves Methods: Retrospective cohort study in 3 PCC. Collection of data was made through electronic medical records (EMR). We selected and reviewed all EMR with diagnosis of CRC from 2010 to march 2017. Demographic data, initial symptoms, secondary referrals, and place of diagnosis were extracted. With these data incidence, characterization of patients with CRC and estimation of waiting times were determined. Results: We reviewed 60,783 EMR from eligible men and women. We found 22 people with confirmed CRC with an incidence of 4,4 per 100,000 inhabitants. The average age at diagnosis was 64.3 years; 45% (10) were men and 55% (12) women. 50% (11) of them had their diagnosis made in the private system. There were records of early symptoms in 63% (14) of patients. 43% (6) had weight loss, 36% (5) hematochezia, 21% (3) abdominal pain, 14% (2) anemia, 14% (2) diarrhea, 14% (2) change in bowel habit, 14% (2) palpable mass, and 13% (2) had been diagnosed due to an acute complication. Regarding waiting times, 4 people had a recorded time from symptoms to first consultation, which was 4.7 months on average. In one patient the time from symptoms to diagnosis was 9 months. 8 people had the time from referral to specialist evaluation on their EMR, which was 23.5 days on average. 7 of these patients were referred with a diagnosis already made. Conclusion: There is a severe lack of information regarding CRC diagnosis. Data obtained through this pilot study were scarce and insufficient to estimate the waiting times between the symptoms and the diagnosis of CRC. One of the reasons for this lack of diagnosis might be that information systems in primary, secondary, and tertiary care are not connected, thus making it impossible to access patient information that might have been diagnosed in the hospitals and stayed there for the whole durations of their treatment. Through these results we might also infer that a large percentage of our patients were diagnosed outside the public network, probably because of the long waiting times for a colonoscopy in the public sector. This could explain the low incidence of CRC. It is necessary to carry out more studies that include secondary-level data as well as qualitative data to determine the diagnostic process of CRC more accurately. Citation Format: Viviana Rodríguez, María Jesús Valdivieso, Felipe Quezada, Maria Elisa Herrera, Javiera Martínez-Gutiérrez. Diagnosing CRC in 3 vulnerable health centers in Santiago, Chile. Not an easy task [abstract]. In: Proceedings of the Tenth AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2017 Sep 25-28; Atlanta, GA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2018;27(7 Suppl):Abstract nr C75.

Details

ISSN :
15387755 and 10559965
Volume :
27
Database :
OpenAIRE
Journal :
Cancer Epidemiology, Biomarkers & Prevention
Accession number :
edsair.doi...........fe80c2a9d1f9a7ab926d3edd84a64d76
Full Text :
https://doi.org/10.1158/1538-7755.disp17-c75